Valproate-induced hyperammonemic delirium in a patient with bipolar affective disorder: A clinical caution

Indian Journal of Pharmacology · Published 2026-03-01 · DOI 10.4103/ijp.ijp_1114_25

Authors being retrieved — see the publisher record. https://doi.org/10.4103/ijp.ijp_1114_25

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Embracing innovations and upholding excellence in pharmacology · Indian Journal of Pharmacology · 2026 · Same journal
A cross-sectional clinical analysis on diabetic foot ulcer and associated risk management · Indian Journal of Pharmacology · 2026 · Same journal
Neuroprotective effects of Vitamin D3 supplementation combination with valproate and perampanel in an experimental model using status epilepticus induction · Indian Journal of Pharmacology · 2026 · Same journal
After the green light: Evaluating drugs in Phase IV studies · Indian Journal of Pharmacology · 2026 · Same journal
Drug-induced mania and parkinsonism in substance use disorder patient: A case report · Indian Journal of Pharmacology · 2026 · Same journal
Optimizing drug availability and reducing wastage through ABC-XYZ inventory management: Insights from a public tertiary cancer hospital in Northern India · Indian Journal of Pharmacology · 2026 · Same journal
Career pathways for pharmacologists in India: A clinical pharmacologist’s perspective · Indian Journal of Pharmacology · 2026 · Same journal
Suzetrigine: A promising analgesic targeting voltage-gated sodium channel · Indian Journal of Pharmacology · 2026 · Same journal
Cost-effectiveness analysis of intradermal versus classical intramuscular COVID-19 vaccine administration: Specific concern on update situation due to emerging Omicron variant · Indian Journal of Pharmacology · 2026 · Same journal
Outer membrane protein LipL21 as a potential candidate against Leptospira interrogans: An in silico prediction · Indian Journal of Pharmacology · 2026 · Same journal